2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with fumarates in 1 studies
Studies (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Trials (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Recent Studies (post-2010) (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Studies (fumarates) | Trials (fumarates) | Recent Studies (post-2010) (fumarates) |
---|---|---|---|---|---|
44 | 0 | 2 | 4,655 | 342 | 1,823 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joseph, K; Kaplan, AP; Tholanikunnel, TE | 1 |
1 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and fumarates
Article | Year |
---|---|
In vitro comparison of bradykinin degradation by aliskiren, a renin inhibitor, and an inhibitor of angiotensin-converting enzyme.
Topics: 3-Mercaptopropionic Acid; Amides; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Endothelial Cells; Fumarates; Humans; Peptidyl-Dipeptidase A; Pulmonary Artery; Renin | 2015 |